ETNB
Income statement / Annual
Last year (2023), 89bio, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, 89bio, Inc.'s net income was -$142.19 M.
See 89bio, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$273,000.00 |
$240,000.00 |
$79,000.00 |
$60,000.00 |
$17,000.00 |
$6,000.00 |
| Gross Profit |
-$273,000.00 |
-$240,000.00 |
-$79,000.00 |
-$60,000.00 |
-$17,000.00 |
-$6,000.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$122.23 M
|
$80.80 M
|
$70.33 M
|
$36.20 M
|
$21.35 M
|
$13.68 M
|
| General & Administrative
Expenses |
$28.97 M
|
$21.45 M
|
$19.41 M
|
$13.16 M
|
$5.29 M
|
$1.48 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$28.97 M
|
$21.45 M
|
$19.41 M
|
$13.16 M
|
$5.29 M
|
$1.48 M
|
| Other Expenses |
$0.00 |
$242,000.00 |
-$526,000.00 |
-$203,000.00 |
-$30.56 M |
-$986,000.00 |
| Operating Expenses |
$151.20 M |
$102.25 M |
$89.74 M |
$49.36 M |
$26.64 M |
$15.16 M |
| Cost And Expenses |
$151.20 M |
$102.25 M |
$89.74 M |
$49.36 M |
$26.64 M |
$15.16 M |
| Interest Income |
$0.00 |
$2.16 M |
$148,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$3.59 M |
$1.92 M |
$674,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$50,000.00
|
$240,000.00
|
$79,000.00
|
$60,000.00
|
$17,000.00
|
$6,000.00
|
| EBITDA |
-$134.46 M
|
-$99.85 M
|
-$90.19 M
|
-$49.50 M
|
-$57.19 M
|
-$16.14 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$12.88 M
|
$242,000.00
|
-$526,000.00
|
-$203,000.00
|
-$30.56 M
|
-$986,000.00
|
| Income Before Tax |
-$138.32 M |
-$102.01 M |
-$90.27 M |
-$49.56 M |
-$57.20 M |
-$16.15 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$3.87 M |
$19,000.00 |
-$147,000.00 |
-$59,000.00 |
$218,000.00 |
$28,000.00 |
| Net Income |
-$142.19 M |
-$102.03 M |
-$90.12 M |
-$49.50 M |
-$57.42 M |
-$16.18 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-2 |
-2.93 |
-4.48 |
-3.08 |
-5.4 |
-3.53 |
| EPS Diluted |
-2 |
-2.93 |
-4.48 |
-3.08 |
-5.4 |
-3.53 |
| Weighted Average Shares
Out |
$71.17 M
|
$34.81 M
|
$20.10 M
|
$16.09 M
|
$10.64 M
|
$4.58 M
|
| Weighted Average Shares
Out Diluted |
$71.17 M
|
$34.81 M
|
$20.10 M
|
$16.09 M
|
$10.64 M
|
$4.58 M
|
| Link |
|
|
|
|
|
|
